scholarly journals IL-33/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis

2021 ◽  
Vol 11 ◽  
Author(s):  
Massimo De Martinis ◽  
Lia Ginaldi ◽  
Maria Maddalena Sirufo ◽  
Enrica Maria Bassino ◽  
Francesca De Pietro ◽  
...  
Keyword(s):  
Vitamin D ◽  
Skin Barrier ◽  
Th2 Cells ◽  
Functional Link ◽  
Mediated Effects ◽  
Metabolic Functions ◽  
Immune Mediated ◽  
Increased Risk ◽  
Pleiotropic Action

Patients with psoriasis (Pso) and, in particular, psoriatic arthritis (PsoA) have an increased risk of developing osteoporosis (OP). It has been shown that OP is among the more common pathologies associated with Pso, mainly due to the well-known osteopenizing conditions coexisting in these patients. Pso and OP share common risk factors, such as vitamin D deficiency and chronic inflammation. Interestingly, the interleukin (IL)-33/ST2 axis, together with vitamin D, is closely related to both Pso and OP. Vitamin D and the IL-33/ST2 signaling pathways are closely involved in bone remodeling, as well as in skin barrier pathophysiology. The production of anti-osteoclastogenic cytokines, e.g., IL-4 and IL-10, is promoted by IL-33 and vitamin D, which are stimulators of both regulatory and Th2 cells. IL-33, together with other Th2 cytokines, shifts osteoclast precursor differentiation towards macrophage and dendritic cells and inhibits receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis by regulating the expression of anti-osteoclastic genes. However, while the vitamin D protective functions in OP and Pso have been definitively ascertained, the overall effect of IL-33 on bone and skin homeostasis, because of its pleiotropic action, is still controversial. Emerging evidence suggests a functional link between vitamin D and the IL-33/ST2 axis, which acts through hormonal influences and immune-mediated effects, as well as cellular and metabolic functions. Based on the actions of vitamin D and IL-33 in Pso and OP, here, we hypothesize the role of their crosstalk in the pathogenesis of both these pathologies.

scholarly journals Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Diana Prieto-Peña ◽  
Sara Remuzgo-Martínez ◽  
Fernanda Genre ◽  
Verónica Pulito-Cueto ◽  
Belén Atienza-Mateo ◽  
...  
Keyword(s):  
Inflammatory Diseases ◽  
Disease Onset ◽  
Immunoglobulin A ◽  
Genetic Network ◽  
Signalling Pathway ◽  
Immune Mediated ◽  
Increased Risk ◽  
Genotype And Allele Frequencies ◽  
Immunoglobulin A Vasculitis

AbstractCytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.

Role of vitamin D and sFlt-1/PlGF ratio in the development of early- and late-onset preeclampsia

2015 ◽  
Vol 53 (7) ◽  
Author(s):  
Indira Álvarez-Fernández ◽  
Belén Prieto ◽  
Verónica Rodríguez ◽  
Yolanda Ruano ◽  
Ana I. Escudero ◽  
...  
Keyword(s):  
Vitamin D ◽  
Late Onset ◽  
Tertiary Care ◽  
Care Hospital ◽  
Hydroxyvitamin D ◽  
Increased Risk ◽  
25 Hydroxyvitamin D ◽  
The Relationship ◽  
Plgf Ratio

AbstractThe imbalanced production of placental biomarkers and vitamin D deficiency have been proposed as risk factors for the development of preeclampsia (PE). However, little is known about the relationship between them and their role in early- versus late-onset PE. The objectives were to assess the role of 25-hydroxyvitamin D [25(OH)D] concentrations and the soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) ratio in the development of early- and late-onset PE; and to evaluate the relationship between 25(OH)D and the biomarkers.A retrospective, full-blinded cohort study was conducted at the Obstetric Emergency Service of a tertiary care hospital. Pregnant women (n=257) attending obstetric triage with suspicion of PE were included. sFlt-1, PlGF and 25(OH)D concentrations were measured by electrochemoluminescence (ECLIA) immunoassay and pregnancy outcome (development of PE) was registered from patients records.PE women showed lower 25(OH)D concentrations at clinical presentation than non-PE women (median: 35.0 nmol/L and 39.6 nmol/L, respectively; p=0.027). Women with 25(OH)D levels <50 nmol/L experienced an increased risk of developing late-onset PE [odds ratio (OR) 4.6, 95% confidence interval (CI) 1.4–15], but no association was found for early-onset PE. However, a sFlt-1/PlGF ratio above the corresponding cutpoints increased the risk of developing both early- and late-onset PE [ORs 58 (95% CI 11–312) and 12 (95% CI 5.0–27), respectively]. No association was found between 25(OH)D levels and sFlt-1/PlGF ratio.Low vitamin D status in women with suspected late-onset PE increases the risk of imminent development of the disease.

scholarly journals The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis

2021 ◽  
Vol 97 (2) ◽  
pp. 16-22
Author(s):  
Zarema R. Khismatullina ◽  
Ksenia M. Koreshkova
Keyword(s):  
Psoriatic Arthritis ◽  
Vascular Wall ◽  
Cardiovascular Complications ◽  
Endothelial Damage ◽  
Very Low Density Lipoproteins ◽  
Cardiovascular Pathology ◽  
Immune Mediated ◽  
Increased Risk ◽  
Complications And Mortality

An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its complications, in particular, a high risk of cardiovascular complications. For PA, dyslipidemias are most characteristic, manifested by an increased level of low and very low density lipoproteins, triglycerides and total cholesterol, which correlates with the activity of the disease. The literature review studied the pathogenesis of dyslipidemias and vascular wall lesions in psoriatic arthritis, analyzed the literature on cardiovascular complications and mortality among patients with PA, studied the issues of total cardiovascular risk, presented the results of numerous clinical studies that allow PA to be considered a disease associated with increased the risk of cardiovascular complications. Considering the role of proinflammatory cytokines in the pathogenesis of psoriatic arthritis, early detection of endothelial lesions represents the most promising direction in the prevention of cardiovascular diseases, which are the main cause of mortality in this group of patients.

scholarly journals Could nutritional supplements act as therapeutic adjuvants in COVID-19?

2021 ◽  
Vol 47 (1) ◽  
Author(s):  
Giorgio Costagliola ◽  
Erika Spada ◽  
Pasquale Comberiati ◽  
Diego G. Peroni
Keyword(s):  
Vitamin D ◽  
Immune System ◽  
Respiratory Infections ◽  
Nutritional Supplements ◽  
Organ Damage ◽  
Immunomodulatory Activity ◽  
Immune Mediated ◽  
Potential Applicability ◽  
Few Data

Abstract Background The role of the immune system and inflammatory response in the pathogenesis of the severe manifestations of coronavirus disease 2019 (COVID-19) is well known. Currently, different therapies active on the immune system are used for the management of COVID-19. The involvement of the immune system also opens the opportunity for the use of nutritional supplements with antimicrobial and immunomodulatory activity. Main aspects Nutritional supplements with antimicrobial and immunomodulatory activity are promising therapeutic adjuvants for the treatment of COVID-19, and also for the prevention of viral spreading. In particular, the role of vitamin D, probiotics, lactoferrin, and zinc is of significant clinical interest, although there are only a few data on their use in COVID-19 patients. Their molecular actions, together with the results of studies performed on other respiratory infections, strongly suggest their potential utility in COVID-19. This article discusses the main properties of these nutritional supplements and their potential applicability in the prevention and treatment of COVID-19. Conclusion The supplementation with vitamin D, probiotics, lactoferrin and zinc could have a role both in preventing SARS-CoV-2 infection and in mitigating the clinical course in infected patients, contributing in the prevention of immune-mediated organ damage.

scholarly journals Calcium and vitamin D in obesity

2012 ◽  
Vol 25 (1) ◽  
pp. 130-141 ◽  
Author(s):  
Qingming Song ◽  
Igor N. Sergeev
Keyword(s):  
Vitamin D ◽  
Clinical Intervention ◽  
Epidemiological Studies ◽  
Vitamin D Status ◽  
Negative State ◽  
Increased Risk ◽  
Research Findings ◽  
Intervention Trials ◽  
Fat Excretion

New and more effective nutritional measures are urgently needed for the prevention of obesity. The role of Ca and vitamin D in obesity has been recently implicated. Low Ca intake and low vitamin D status have been linked with an increased risk of obesity in epidemiological studies; however, clinical intervention trials designed to test this association have produced controversial results. The suggested anti-obesity mechanisms of Ca and vitamin D include the regulation of adipocyte death (apoptosis), adipogenesis and lipid metabolism. Dietary Ca has been also shown to increase faecal fat excretion. The potential role of Ca and vitamin D in shifting energy balance towards a more negative state is an area of considerable interest. Ultimately, a review of recent research findings does not allow the reaching of a definitive conclusion that increasing Ca intake and rising vitamin D status will influence fat mass and body weight or decrease the risk of obesity and overweight.

scholarly journals CONDITIONALLY ESSENTIAL TRACE ELEMENTS IN NUTRITION OF VEGETARIANS AND VEGANS: FLUORINE, SILICON, BROMINE, BORON

2021 ◽  
Vol 22 (1) ◽  
pp. 32-43
Author(s):  
A.V. Galchenko ◽  
◽  
A.A. Sherstneva ◽  
M.M. Levina ◽  
◽  
...  
Keyword(s):  
Vitamin D ◽  
Trace Elements ◽  
Bone Tissue ◽  
Tooth Enamel ◽  
Metabolic Disturbances ◽  
Oral Flora ◽  
Plant Foods ◽  
Increased Risk ◽  
Essential Trace Elements

A brief review of the physiology of conditionally essential trace elements and their status among vegetarians and vegans is presented. To date, the biological role of conditionally essential trace elements has been studied much worse than the role of essential trace elements and, especially, macroelements. Nevertheless, they perform a number of important functions in the human body, and the development of their deficiency may lead to unpleasant consequences. Fluorine plays an important role in calcium-phosphorus metabolism and bone tissue development. In addition, it is necessary to maintain normal oral flora. With its deficiency, the risk of osteoporosis development increases while the resistance of tooth enamel to bacterial damage decreases. Despite the evidence that vegetarians are more likely to develop caries than omnivores, it is premature to conclude that they are poorly supplied with fluoride, primarily because drinking water is still the main source of fluoride. The most studied function of silicon is its involvement in the collagen synthesis. Thus, with silicon defi-ciency, the formation of connective tissue, including the organic matrix of the bones, is disturbed. Despite the fact that silicon is mainly found in plant foods, vegans should be mindful about its status, since they have an increased risk of osteopenia and osteoporosis. There is a lack of data on the physiological significance of bromine. Presumably, it is involved in the activa-tion of certain digestive enzymes, inhibitory processes in the nervous system. Although vegetarians and vegans seem to consume less bromine than omnivores, they are probably at a higher risk of intoxication with this element. This is due to the fact that bromine-containing pesticides are actively used in agriculture and can accumulate in plants. Vegetarians and vegans consume more plant foods. The situation is aggravated by the fact that bromine accumulates more actively against the background of iodine deficiency, which is often observed in these population groups. Boron plays a role in the glucose and lipid metabolism, as well as in the vitamin D, calcium and phosphates exchange, thus participating in the formation of an inorganic matrix of bones. It is unlikely that vegetarians and vegans have an increased risk of developing nutritional deficiency of boron compared to omnivores. However, considering data on a higher risk of vitamin D and calcium deficiency and osteoporosis, monitoring and correction of boron status can affect the prevalence of metabolic disturbances in bone tissue among vegans.

scholarly journals Possible Role of Vitamin D in Celiac Disease Onset

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1051 ◽  
Author(s):  
Giorgia Vici ◽  
Dalia Camilletti ◽  
Valeria Polzonetti
Keyword(s):  
Vitamin D ◽  
Celiac Disease ◽  
Immune Modulation ◽  
Disease Onset ◽  
Gluten Protein ◽  
Skeletal System ◽  
Immune Mediated ◽  
Key Factor ◽  
System Maintenance

Beside skeletal system maintenance and protection, possible extra-calcium roles of vitamin D have been recently described. In particular, studies have investigated possible roles of vitamin D as a key modulator of inflammation and immune mechanisms and of the intestinal mucosa barrier. In this regard, vitamin D has been considered as a factor that affects different conditions such as immune-mediated diseases. The new emerging role of vitamin D and its involvement in immune modulation has led it to be considered as a possible key factor involved in celiac disease (CD) onset. CD is a chronic immune-mediated enteropathy of the small intestine that is triggered by dietary gluten protein exposure in individuals who are genetically predisposed. However, along with gluten, other environmental factors are also involved in CD onset. The renewed interest in a molecule that offers great possibilities for new roles has led to an increase in studies, although there remains a lack of studies aimed at contextualizing the role of vitamin D on CD. This review aims to define the possible role of vitamin D in CD onset as it is presently understood, taking into account potential links among vitamin D, the immune system and CD.

scholarly journals Vitamin D and cardiometabolic health: a review of the evidence

2010 ◽  
Vol 24 (1) ◽  
pp. 1-20 ◽  
Author(s):  
Siobhan Muldowney ◽  
Mairead Kiely
Keyword(s):  
Risk Factors ◽  
Experimental Data ◽  
Vitamin D ◽  
Seasonal Effects ◽  
Cardiometabolic Health ◽  
Vitamin D Status ◽  
Cvd Risk ◽  
Increased Risk ◽  
Shared Risk

The cardiometabolic syndrome (MetS) is a clustering of related metabolic abnormalities including abdominal adiposity, insulin resistance, hypertension, dyslipidaemia and increased inflammatory and thrombotic markers, which is linked to increased risk of type 2 diabetes, CVD and overall mortality. Several cross-sectional and prospective studies have shown an association between low vitamin D status, as indicated by concentrations of serum 25-hydroxyvitamin D (s25(OH)D), and increased prevalence of the MetS and individual CVD risk factors. These epidemiological observations are supported by mechanistic studies but experimental data are limited. The available data from intervention studies are largely confounded as most vitamin D supplementation trials were mainly carried out to explore the role of Ca in CVD and include Ca in the treatment arms. Inadequate consideration of seasonal effects on s25(OH)D concentrations is also a common design flaw in most studies. Further complications arise from shared risk factors such as adiposity and ageing, which predispose individuals to exhibit both a more pronounced risk profile and relatively lower s25(OH)D concentrations. In conclusion, while epidemiological associations are promising and a rationale for low vitamin D status as a potentially modifiable risk factor for CVD is supported by mechanistic data, suitable experimental data from appropriately designed trials are just beginning to emerge. As yet, this body of literature is too immature to draw firm conclusions on the role of vitamin D in CVD prevention. Carefully controlled vitamin D trials in well-described population groups using intervention doses that are titrated against target s25(OH)D concentrations could yield potentially valuable outcomes that may have a positive impact on CVD risk modification.

scholarly journals Role of Vitamin D in the Clinical Course of Nasal Polyposis

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 855
Author(s):  
Giuseppe Murdaca ◽  
Francesca Paladin ◽  
Sebastiano Gangemi
Keyword(s):  
Vitamin D ◽  
Therapeutic Strategy ◽  
Nasal Polyposis ◽  
Clinical Course ◽  
Innate And Adaptive Immunity ◽  
Immune Mediated ◽  
Inflammatory Processes ◽  
Anti Oxidant ◽  
Oxidant Effect

Vitamin D is a lipo-soluble hormone well known for its effects on calcium homeostasis and bone metabolism. Recently, there has been growing interest in the extraskeletal effects of vitamin D. In particular, recent studies have highlighted how vitamin D plays a fundamental role in immunomodulation processes in the context of both innate and adaptive immunity, with consequent anti-inflammatory and anti-oxidant effect in different immune-mediated pathologies, such as systemic sclerosis, psoriasis, atopic dermatitis and rheumatoid arthritis; as well as in various pro-inflammatory processes affecting the airways, including chronic rhinosinusitis with (CRSwNP) or without (CRSsNP) nasal polyposis. We analyze the role of vitamin D in the genesis and progression of CRSwNP/sNP and its supplementation as a safe and valid therapeutic strategy capable of improving the clinical outcome of standard therapies.

Sign in / Sign up

Export Citation Format

Share Document